A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
A judge has approved a confidential settlement in a class action against KPMG and nine former Gunns Plantations directors over the failure of six managed investment schemes for eucalyptus wood in Tasmania.
Lawyerly’s Litigation Law Firms of 2022 racked up precedent-setting victories in a year that continued to see major developments in class action law.
A class action against KPMG and nine former Gunns Plantations directors over the failure of six managed investment schemes for eucalyptus wood in Tasmania has settled for a confidential amount, with a judge poised to approve the deal.
A class action against KPMG over the failure of six managed investment schemes for eucalyptus wood in Tasmania has settled its claims against former Tasmanian Premier Robin Gray.
A judge has thrown out a long-running class action on behalf of 20 local councils in NSW alleging insurer JLT Risk Solutions charged them hundreds of millions of dollars in excessive premiums over nine years.
A class action against KPMG over the failure of six managed investment schemes for eucalyptus wood in Tasmania can’t add new claims against the accounting firm three months out from trial.
A court has found that flying flags associated with the Eureka Rebellion or displaying material bearing union mottos and indicia at construction sites contravenes the Building Code.
An appeals court has unanimously rejected the Commissioner of Taxation’s latest bid to block Shell’s $2.3 billion tax deduction for the cost of exploration activities conducted as part of the Browse LNG project off the coast of Western Australia.
Insurance broker JLT Risk Solutions has opposed an application by a group of NSW councils to add misleading and deceptive conduct allegations to a long-running class action, claiming the changes would force the vacation of a five-week trial due to start in October.